INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT

SAN DIEGO, Feb. 17, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), have until this upcoming Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit.  Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the Applied Therapeutics class action lawsuit charges Applied Therapeutics and certain of Applied Therapeutics' executives with violations of the Securities Exchange Act of 1934.